Related Experiment Video
Updated: Aug 31, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.1K
Economic aspects of treating seizure clusters
1Department of Neurology, Emory University, Atlanta, Georgia, USA.
Epilepsia
|August 23, 2022
Summary
Seizure clusters have significant economic and clinical costs. Effective rescue medications (RMs) likely offer economic benefits, justifying their use for many patients.
Area of Science:
- Clinical Neurology
- Health Economics
Background:
- Seizure clusters can lead to severe clinical events and substantial economic burdens for individuals and society.
- Economic evaluations are crucial for managing seizure clusters, balancing treatment costs against potential adverse outcomes.
Purpose of the Study:
- To analyze the economic implications of seizure clusters and the cost-effectiveness of rescue medications (RMs).
- To highlight the need for data on RM effectiveness and associated costs versus untreated clusters.
Main Methods:
- Review of economic analyses relevant to medical interventions for seizure clusters.
- Consideration of direct costs (RM, emergency care) and indirect costs (lost employment).
Main Results:
- Limited direct comparative data exists on using RMs versus no treatment for seizure clusters.
- The high cost of seizure cluster consequences suggests effective RMs are likely economically viable.
Conclusions:
- Effective rescue medications for seizure clusters present a strong case for both medical and economic benefits.
- Further economic analysis is needed to guide optimal management strategies for seizure clusters.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
261
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
261
01:13Seizures: Classification
565
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
565
01:30Electroconvulsive Therapy
134
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
134
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
578
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
578
01:14Antiepileptic Drugs: Glutamate Antagonists
491
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
491
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
423
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
423